Curis, Inc. (CRIS)
0.85
-0.26
(-23.42%)
USD |
NASDAQ |
Nov 05, 16:00
0.7803
-0.07
(-8.20%)
After-Hours: 20:00
Curis Net Income (TTM) : -21.15M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.15M |
| March 31, 2026 | -21.16M |
| December 31, 2025 | -7.582M |
| September 30, 2025 | -36.56M |
| June 30, 2025 | -38.92M |
| March 31, 2025 | -42.13M |
| December 31, 2024 | -43.39M |
| September 30, 2024 | -45.48M |
| June 30, 2024 | -47.57M |
| March 31, 2024 | -47.73M |
| December 31, 2023 | -47.41M |
| September 30, 2023 | -47.03M |
| June 30, 2023 | -48.14M |
| March 31, 2023 | -52.12M |
| December 31, 2022 | -56.67M |
| September 30, 2022 | -58.96M |
| June 30, 2022 | -56.72M |
| March 31, 2022 | -51.62M |
| December 31, 2021 | -45.44M |
| September 30, 2021 | -39.33M |
| June 30, 2021 | -34.26M |
| March 31, 2021 | -30.13M |
| December 31, 2020 | -29.91M |
| September 30, 2020 | -31.00M |
| June 30, 2020 | -31.46M |
| Date | Value |
|---|---|
| March 31, 2020 | -31.97M |
| December 31, 2019 | -32.14M |
| September 30, 2019 | -29.47M |
| June 30, 2019 | -30.26M |
| March 31, 2019 | -31.71M |
| December 31, 2018 | -32.58M |
| September 30, 2018 | -34.66M |
| June 30, 2018 | -42.90M |
| March 31, 2018 | -48.32M |
| December 31, 2017 | -53.32M |
| September 30, 2017 | -56.62M |
| June 30, 2017 | -69.51M |
| March 31, 2017 | -66.71M |
| December 31, 2016 | -60.41M |
| September 30, 2016 | -62.54M |
| June 30, 2016 | -39.74M |
| March 31, 2016 | -36.57M |
| December 31, 2015 | -58.98M |
| September 30, 2015 | -51.21M |
| June 30, 2015 | -51.25M |
| March 31, 2015 | -45.01M |
| December 31, 2014 | -18.73M |
| September 30, 2014 | -17.24M |
| June 30, 2014 | -13.53M |
| March 31, 2014 | -12.92M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 9.391B |
| Anika Therapeutics, Inc. | -3.121M |
| BioCryst Pharmaceuticals, Inc. | -359.66M |
| Imunon, Inc. | -14.72M |